Last reviewed · How we verify
NCT05867316
Supplementing Brief Psychotherapy With a Mobile App
NA trial testing Unified Protocol in Suicide and Self-harm in 40 participants. Completed in 6 June 2024.
7 May 2024
Quick facts
| Lead sponsor | Rutgers, The State University of New Jersey |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 14 September 2023 |
| Primary completion | 7 May 2024 |
| Estimated completion | 6 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Unified Protocol
Conditions studied
- Suicide and Self-harm — all drugs for Suicide and Self-harm →
- Emotion Regulation — all drugs for Emotion Regulation →
Sponsor
Rutgers, The State University of New Jersey
Who can join
18 and older, any sex, with Suicide and Self-harm or Emotion Regulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05867316
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Unified Protocol
Trials testing the same drug.
- NCT07070531 — Unified Protocol in Penitentiary Facilities · NA · not yet recruiting
- NCT06906991 — Multicomponent FIBROWALK Therapy Plus Unified Protocol for Emotional Regulation in Individuals With Fibromyalgia · NA · not yet recruiting
- NCT06384196 — Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression · NA · recruiting
- NCT06722781 — Trial of an Online Group Psychotherapy Intervention for Common Mental Health Disorders · NA · recruiting
- NCT06777693 — The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Older Adults: a Feasibility Study · NA · enrolling by invitation
Other recruiting trials for Suicide and Self-harm
Currently open trials in the same condition.
- NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting
- NCT05842863 — Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk · NA · recruiting
- NCT05180344 — Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Tria · NA · recruiting
- NCT06476886 — Intensive Crisis Intervention · NA · recruiting
- NCT06273995 — Telehealth Behavioral Activation for Teens · NA · recruiting
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
- NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
- NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
- NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
- NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
- NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05867316 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
- Last refreshed: 13 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05867316.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing